Background Image
Table of Contents Table of Contents
Previous Page  92 / 124 Next Page
Information
Show Menu
Previous Page 92 / 124 Next Page
Page Background

92

2014 Annual Report

After that, three documents were published regarding the international

guidelines for in vitro diagnosis medical devices. These documents were

published by a Taiwan-championed work group, named as WG1a. The

documents later were endorsed by the AHWP and became official AHWP

documents. Research funds from the Bill & Melinda Gates Foundation were

received to host on international IVD medical devices meeting in 2013.

b. In 2013, TFDA continued to participate in the APEC Life Science Innovation

Forum Planning Group (LSIF-PG) meetings and Regulatory Harmonization

Steering Committee (LSIF-RHSC) meeting. TFDA championed two priority

work areas, including

Good Review Practice

(GRevP) and Combination

Products in RHSC.

(4) The cosmetic regulations will be amended to align with the international trends

Taiwan government is working on amending cosmetic regulations in order

to harmonize with the international regulations and keep the communication

channels open for the industry.

4. Vertical Alliance on Drug Abuse Prevention

In accordance with the provisions of international conventions, TFDA rigidly

follows the written instruction for all the import and export control drugs required

documents. International cooperation was emphasized. Safeguarding the

distribution of legitimate controlled drugs is our mission. In 2013, 21 out of the

The AHWP WG1a-PAHWP-LSHTM Joint Conference on International IVD Medical Devices Regulations